Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Nov 9, 2022
- Accession no.
- 0001415889-22-011245
- Filed
- Nov 9, 2022
- Trade date
- Nov 7-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 5 derivative transactions. Open-market sales total $474.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Common Stock | MOption exerciseAcquired | +2,413 | $1.74 | +$4,198.62 | 2,413 | Direct | |
| Nov 7, 2022 | Common Stock | MOption exerciseAcquired | +15,214 | $2.14 | +$32,557.96 | 17,627 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −11,122 | $17.79F2 | −$197,860.38 | 6,505 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −3,359 | $18.58F3 | −$62,410.22 | 3,146 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −1,486 | $19.57F4 | −$29,081.02 | 1,660 | Direct | |
| Nov 7, 2022 | Common Stock | SSaleDisposed | −1,660 | $20.24F5 | −$33,598.4 | 0 | Direct | |
| Nov 8, 2022 | Common Stock | MOption exerciseAcquired | +8,373 | $2.14 | +$17,918.22 | 8,373 | Direct | |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −8,373 | $18.09F6 | −$151,467.57 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Common Stock | MOption exerciseDisposed | −906 | $0.00 | $0 | 12,677 | Direct | |
| Nov 7, 2022 | Common Stock | MOption exerciseDisposed | −1,507 | $0.00 | $0 | 31,643 | Direct | |
| Nov 7, 2022 | Common Stock | MOption exerciseDisposed | −1,019 | $0.00 | $0 | 29,533 | Direct | |
| Nov 7, 2022 | Common Stock | MOption exerciseDisposed | −14,195 | $0.00 | $0 | 284,971 | Direct | |
| Nov 8, 2022 | Common Stock | MOption exerciseDisposed | −8,373 | $0.00 | $0 | 276,598 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.055 to $18.05, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.07 to $19.01, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.10 to $20.07, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.11 to $20.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.555 to $18.510, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
Officer Title: President, Chief Operating Officer and Secretary